Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

340 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT02553317

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Birmingham, Alabama, United States
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site Boston, Massachusetts, United States
View all 101 locations
View Trial Details
Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT01151423

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Washington D.C., District of Columbia, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site St Louis, Missouri, United States
View all 51 locations
View Trial Details
Completed

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT03922308

Conditions
Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View all 24 locations
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

NCT05566990

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Dong-A University Hospital Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
View Trial Details

Related conditions